A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
Public ClinicalTrials.gov record NCT01455493. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, single-arm, open-label Phase II study to evaluate the activity of GDC-0980 in patients with recurrent or persistent endometrial cancer. The safety, tolerability, and pharmacokinetics of GDC-0980 will also be evaluated.
Study identification
- NCT ID
- NCT01455493
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 56 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2011 (Type not available)
- Primary completion
- Mar 2013 (Actual)
- Completion
- Jan 2014 (Actual)
- Last update posted
- Aug 11, 2016
2011 – 2014
United States locations
- U.S. sites
- 28
- U.S. states
- 19
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85013 | — |
| Not listed | Newport Beach | California | 92663 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | Palo Alto | California | 94305 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | Denver | Colorado | 80220 | — |
| Not listed | New Haven | Connecticut | 06511 | — |
| Not listed | Boca Raton | Florida | 33487 | — |
| Not listed | Orlando | Florida | 32804 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Hinsdale | Illinois | 60521 | — |
| Not listed | Indianapolis | Indiana | 46237 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Scarborough | Maine | 04074 | — |
| Not listed | Baltimore | Maryland | 21231 | — |
| Not listed | Boston | Massachusetts | 02115-6084 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Voorhees Township | New Jersey | 08043 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | New York | New York | 10017 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | Abington | Pennsylvania | 19001 | — |
| Not listed | Pittsburgh | Pennsylvania | 15213 | — |
| Not listed | Salt Lake City | Utah | 84112 | — |
| Not listed | Seattle | Washington | 98195 | — |
| Not listed | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01455493, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2016 · Synced Oct 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01455493 live on ClinicalTrials.gov.